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Improving acid resistance, while maintaining the excellent mechanical stability is crucial in the
development of a sustained and safe oral geopolymer dosage form for highly potent opioids. In the
present work, commercially available Methacrylic acid–ethyl acrylate copolymer, Polyethylene-glycol
(PEG) and Alginate polymer excipients were included in dissolved or powder form in geopolymer
pellets to improve the release properties of Zolpidem, herein acting as a model drug for the highly
potent opioid Fentanyl. Scanning electron microscopy, compression strength tests and drug release
experiments, in gastric pH 1 and intestinal pH 6.8 conditions, were performed. The polymer excipients,
with an exception for PEG, reduced the drug release rate in pH 1 due to their ability to keep the pellets
in shape, in combination with the introduction of an insoluble excipient, and thereby maintain a barrier
towards drug diffusion and release. Neither geopolymer compression strength nor the release in pH
6.8 was considerably impaired by the incorporation of the polymer excipients. The geopolymer/
polymer composites combine high mechanical strength and good release properties under both gastric
and intestinal pH conditions, and are therefore promising oral dosage forms for sustained release of
highly potent opioids.
& 2012 Elsevier B.V. All rights reserved.1. Introduction
Controlled and sustained release of drugs is important for
patients requiring medicinal treatment around the clock. One
such example is cancer patients with chronic or persistent pain
given very potent opioids, such as Fentanyl [1,2,3]. However,
because of the high potency and narrow therapeutic window of
these drugs, even small variations in plasma concentrations could
lead to severe side effects [4]. As a consequence, when formulat-
ing potent drugs into sustained release dosage forms, it is of
special importance to have control over the drug release proﬁle
and thus also the drug absorption. Geopolymers have recently
been suggested [5,6] for controlled and safe release of highly
potent opioids due to their mechanical and chemical integrity.
This class of materials has mainly been suggested to replace
Portland cement as a construction material due to the lower
energy required in its preparation [7]. Geopolymers are formed in
a dissolution and precipitation process using aluminosilicate
precursor materials, such as thermally treated kaolin, in alkalinell rights reserved.
aterials Science, Department
ppsala University, Box 534,
S. Bredenberg).media and silicate solutions [8]. The ﬁnal product consists of an
amorphous three dimensional network of tetravalent silica and
alumina species with the charge compensating single valent
cations, e.g. Naþ . The water used in synthesis is expelled during
reaction to form the pores after drying [7,8]. Geopolymers with
different microstructure may be formed by varying the alumino-
silicate precursor type [7], the stoichiometric ratio of silica [9], the
alkali hydroxide and water contents [10] as well as the reaction
temperature and pressure [7].
Using pore-network modeling and characterization, we have
shown that it is possible to tune the porous geopolymer micro-
structure and the resulting molecular diffusion coefﬁcients of
drugs incorporated in this structure to span over two orders in
magnitude [10]. It has also been shown that Fentanyl was
released at a considerably higher rate under low pH conditions
(pH 1; mimicking acidic stomach conditions) as compared to
neutral pH (pH 6.8 mimicking small intestine conditions), which
was partly related to the higher solubility of Fentanyl at low pH
[5]. Apart from an increased drug solubility at low pH, geopoly-
mer degradation was also believed to be a contributing cause of
the increased Fentanyl release rate [5], a problem that is also
present for other clay-based delivery vehicles [11]. Geopolymers
are depolymerized [7] in acidic media in a process where the
charge balancing cations (Naþ) in the geopolymer framework are
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þ ions from the solution along with an
electrophilic attack by acid protons on the polymeric silalate
Si–O–Al and siloxo Si–O–Si bonds. The ejection of tetrahedral
alumina and silanol species have been observed [12] to be
followed by immediate formation of new phases, such as zeolites
and gypsum crystals [7,13].
The aim of the work is to investigate the inﬂuence of incorporat-
ing different polymer excipients in pellets made of one geopolymer
formulation on the mechanical strength as well as on the release
behavior of Zolpidem from the same. Zolpidem is chosen as the
model drug in this study due to safety considerations during
handling; it is considerably less potent than the physico-chemically
similar and highly potent Fentanyl [5].2. Materials and method
2.1. Materials
Kaolin (Al2Si2O5(OH)4), fumed silica (SiO2, 7 nm particle size),
reagent grade sodium hydroxide (NaOH) (Sigma-Aldrich, Stockholm,
Sweden) and Zolpidem tartrate (C19H21N3O, Cambrex AB, USA) were
used as received. The investigated polymer excipients were Kollicoat
MAE 100P (BASF, Luwigshafen, Germany), Poly(ethylene glycol)
(#81300, Sigma-Aldrich, Stockholm, Sweden), Protanal L10/60 and
L10/60 LS with a high (GcE70%) and low (GcE40%) guluronic acid
content Gc, respectively (kindly donated by the FMC biopolymer,
Norway). In addition, the polymer excipient Eastman CAP (Eastman
Chemical Company, USA) was brieﬂy tested and discarded. Impor-
tant polymer excipient characteristics are as summarized in Table 1.
2.2. Methods
2.2.1. Synthesis
Metakaolin (Al2O3 2SiO2) was initially prepared by thermal
treatment of Kaolinite at 800 1C for 2 h. Sodium silicate solution
(waterglass) was prepared by mixing sodium hydroxide, fumed silica
and de-ionized water until a clear and viscous solution was formed.
A geopolymer paste (Si/Al¼1.77, Na2O/Al2O3¼1.4, H2O/Al2O3¼14)
was prepared by mixing metakaolin, waterglass and the model drug
Zolpidem tartate without (Control) or with 1 g of polymer excipient
in dissolved or powder form per 6.5 g Metakaolin in a glass mortar
until a uniform paste was formed. The paste was molded in
cylindrically shaped Teﬂons molds resulting in pellets of the size
1.5 mm1.5 mm (diameterheight) and in rubber molds resulting
in rods for compression strength tests with a corresponding size of
6 mm12mm. The geopolymer precursor was cured at 37 1C for
48 h in 100% relative humidity (RH) and stored in an 11% RH
dessicator before analysis. The pellets prepared from pastes contain-
ing polymers in dissolved form and powder form were named after
the polymer used with the extension D or P, respectively. In addition
to the samples named Control, Ko D, Ko P, PEG D, Alg-G P and Alg-M
P, samples made from geopolymer pastes containing only half the
amount of powder form Kollicoat and PEG (i.e. 0.5 g of excipient per
6.5 g of Metakaolin); viz. Ko-h P and PEG-h D, were prepared.Table 1
Polymer excipient speciﬁcations.
Trade name Base compound/chemical name
Kollicoat MAE 100P 1:1 Methacrylic acid/ethyl acrylate
Polyethylene glycol Polyethylene glycol (MW 20 k)
Protanal LF10/60 Alginic acid (GcE70%)
Protanal LF10/60 LS Alginic acid (GcE40%)
a G denotes a higher ratio of guluronic acid.
b M denotes a higher ratio of manuronic acid.Compositions with pre-dissolved Alginate (Alg-G D and Alg-M D)
were prepared, but discarded as alginate degraded in the caustic
synthesis environment [14]. PEG P samples were also prepared, but
the PEG powder did not homogenously mix into geopolymer paste,
which therefore was discarded.
2.2.2. Scanning electron microscopy (SEM)
The SEM micrographs of fracture surfaces of the pellets were
taken with a Leo 1550 FEG microscope (Zeiss, UK) equipped with
an in-lens detector. A thin gold/palladium layer was sputtered
onto the fracture surfaces of the non-conducting samples prior to
analysis to minimize charging of the samples. The analysis was
performed with 5 kV acceleration voltage.
2.2.3. Compression strength
The compression strength of each composition (n¼7) was
measured as the maximum pressure that could be applied on the
6 mm12 mm rods before breakage using an Autograph AGS-H
universal testing equipment (Shimadzu Corp., Japan).
2.2.4. Drug release measurements
Zolpidem release from the pellets was evaluated in a USP-2
dissolution bath (Sotax AT7 Smart, Sotax AG, Switzerland)
equipped with 1000 ml vessels (37 1C, 50 rpm). 400 mg of pellets
were placed in each vessel containing 400 ml of either phosphate
buffer set to pH 6.8 or 0.1 M HCl, pH 1. In all experiments the
quantities of pellets corresponded to a drug amount below 10% of
the drug solubility in order to ensure that sink conditions always
prevailed. Aliquots (1 ml) were manually withdrawn at different
time points during the release, and the concentration of drug in
these samples was analyzed with a UV/VIS photo-spectrometer
(Shimadzu 1800, Japan). Any possible interference of dissolved
polymer excipients in the drug absorbance/concentration mea-
surements was evaluated by separately dissolving the polymers
in the relevant buffer solutions. The absorbance of the polymers
was found to be considerably lower than for the Zolpidem drug at
its absorption peaks (241 and 300 nm). A photograph (Cybershot
DSC-HX100V, Sony Corp., Japan) of the bottom of each dissolution
vessel was taken after 6 h of drug release in pH 1. The drug release
was studied for 6 h in pH 1 and for 24 h in pH 6.8. These total
release times were chosen to mimic in vivo residence time of the
pellets in the stomach and the intestinal tract.3. Results and discussion
3.1. Pellet microstructure
Fig. 1 shows SEM micrographs of typical fracture surfaces of
geopolymer pellets samples without added polymers (panel a) as
well as samples of the same geopolymer composition with
polymers incorporated (panels b–f). The geopolymer sol–gel
reaction allows pellets of any size and shape to be synthesized.
When mixing the pre-heated kaolinite in the alkaline waterglass,
the kaolinite is dissolved, forming reactive Si- and Al-species thatAbbreviation Soluble in pH
Ko 45.5
PEG Solubility is pH independent
Alg-Ga 44.0
Alg-Mb 44.0
Fig. 1. SEM micrographs of geopolymer without polymers added (a) as well as with added polymer excipients in dissolved (b, c) or powder (d–f) form.
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meshwork of clusters [7], as can be observed in Fig. 1a. It should
be noted that the diameter of native pores for similar geopolymer
composition (Si/Al¼1.77, Na2O/Al2O3¼1.4, H2O/Al2O3¼14) has
been found to be in the 10–20 nm range, [10] which is in
conformity with the pores observed upon a closer inspection of
the Control sample in Fig. 1a.
Adding pre-dissolved methacrylic acid/ethyl acrylate copoly-
mer in the geopolymer paste during synthesis resulted in a fairly
homogeneous distribution of polymer in the geopolymer struc-
ture without evident signs of lumps of aggregated polymer, cf.
Ko D, Fig. 1b. Conversely, the use of pre-dissolved PEG in
synthesis resulted in larger polymer bundles (6 mm, cf. Fig. 1c)
as observed by SEM, despite that no phase separation was seen
during synthesis. Both the commercially available Kollicoat MAE
100P and PEG dissolved in 2 M NaOH and formed a clear solution
prior to synthesis. However, adding Kollicoat in powder form
during synthesis resulted in micrometer-sized voids (1 mm) in
the geopolymer pellet structure with the smooth polymer cover-
ing the interior void surfaces (sample Ko P) as evident from
Fig. 1d. The same type of voids was found in the structure of
geopolymer pellets containing powder form Alg-G and Alg-M, cf.
Fig. 1e–f. Hence, the voids are most likely footprints after larger
powder particles that have dissolved and created a polymer layer
on the surface of the walls surrounding the voids while the voids
created in the PEG sample (Fig. 1c) are likely caused by a phase
separation. The polymer layer obviously also penetrated the
native pores of the geopolymer structure neighboring the voids
as indicated by the smooth structure at a distance of r0.5 mm
from the voids (Fig. 1c–f) in the otherwise rather particulate
geopolymer fracture surface. In Fig. 1a–d, elongated voids are
visible, and are most likely stemming from unreacted metakao-
linite sheets ripped off during the SEM sample preparation
process. The incorporated Zolpidem was not observed in SEM
due to the low drug content (0.75 vol%).3.2. Compression strength
Fig. 2a shows the measured compression strengths of the
samples under study. It can be observed that the samples prepared
with polymers in powder form had lower compression strength
than the pure geopolymer Control sample and the samples synthe-
sized with pre-dissolved polymers. The Alg-G P and Alg-M P samples
had compression strengths that were statistically signiﬁcant lower
than the Control, the Ko D and the Ko h D samples, whereas the PEG
D samples had a compression strength that was signiﬁcantly lower
than the Ko h D sample but with an average value lower than both
Ko D and Control.
The compression strength of a material depends on how much
compression load per area the microstructure of a material can
withstand before collapsing. Porous solids display lower compres-
sion strengths than their non-porous counterparts due to the
reduction of load-bearing solid material in the former. Inhomo-
geneities, naturally found in the pore structure or formed via
inclusion of foreign materials (e.g. polymer), may create stress
concentrations in the structure when a compressive force is
applied. When the maximum local stress that the structure can
withstand is exceeded, a crack forms that eventually propagates,
and leads to material breakage. More and larger structural inho-
mogeneities generally increase the probability of crack formation;
thus, the compression strength is proportional to size and density
of defect sites [15]. A sufﬁciently well dispersed polymer, i.e. only
residing in the native geopolymer pores, might conceivably even
reduce the overall sample porosity, and increase compression
strength of the material. The measured compression strengths for
Ko D and Ko-h D were, however, not found to be statistically
signiﬁcantly different from the Control sample although the
average value for the Ko h D sample was somewhat larger.
The somewhat lower compression strengths of the samples
synthesized with polymers in powder form for the alginates and
solution form for PEG are most probably caused by a higher
Fig. 2. Compression strength data with error bars denoting standard deviation of at least 7 rods (a). Photograph of pellets on the bottom of the dissolution vessel after 6 h
in pH 1 (b). Zolpidem release in pH 1 (c) and pH 6.8 (d) dissolution media. The data points and error bars denote averages and standard deviations from 3 consecutive
measurements.
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observed in SEM (Fig. 1c–f), which are expected to weaken the
overall mechanical stability of the matrix as reasoned above.
Reducing the amount of added polymer (compare PEG-h D and
PEG D) thus leads to increased compression strength.
3.3. Drug release
Fig. 2b shows photographs of a selection of pellets at the
bottom of the USP-2 dissolution vessels after 6 h of release in pH
1. Pellets containing polymer excipients insoluble in pH 1 (i.e. Ko,
Alg-G and Alg-M, cf. Table 1) were observed to maintain their
shape during release, whereas PEG D (not shown in the ﬁgure)
and Control sample pellets eroded into ﬁne grains within a few
hours of release in low pH. Comparing the pellet containing
methacrylic acid/ethyl acrylate copolymer, the Ko D pellets
appeared to stay intact during release, while a few grains were
seen to detach from the pellets of both Ko-h D and Ko P samples
after 6 h in pH 1. The Alg-G P and Alg-M P pellets (not shown in
the ﬁgure) formed a single piece of what appeared to be an
alginate gel precipitate during release [16]. The alkaline geopoly-
mer synthesis conditions most likely give rise to an initially
higher local pH inside the pellet pores [17] during the ﬁrst stagesof release. Thus, a pH gradient, directed inwards from the pellet
surface and reaching a maximum value immediately after pene-
tration of the release media into the pellet, most likely exists. The
higher pH inside the pellets allows for dissolution of the Alginate
polymer, which starts to diffuse concomitantly with the drug.
After the maximum pH gradient is reached, the pH inside the
pellets is expected to decrease with time as the buffer protons
diffuse into the pellet, reaching the dissolved alginate polymer
that re-precipitates.
Fig. 2c and d shows the release of Zolpidem from the
geopolymer pellets in pH 1 and pH 6.8, respectively. The release
curve for PEG-h D is not shown in Fig. 2c since it almost
completely overlays the release curve for PEG D. Only the samples
from which the Zolpidem release was slower than for the Control
sample were tested in pH 6.8. Thus, the samples containing PEG
are not shown in Fig. 2d.
The two release medias were used to mimic the pH condition
of the stomach (the pH in the stomach can be as low as 1) and
gastrointestinal tract, respectively. The Control sample released
its entire drug content within 4–5 h in pH 1, Fig. 2c, and about
70% of its drug content within 24 h in pH 6.8, Fig. 2d, in
accordance with what has been observed earlier for Zolpidem
release from pure geopolymer samples [5]. As mentioned in the
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6.8, can be partly explained by the higher solubility of the weak
base drug at lower pH and partly by the degradation of the
geopolymer under acidic conditions [5]. In Fig. 2b it was shown
that the Control sample pellets turned into grains in the dissolu-
tion vessel during release in pH 1. However, the pellets containing
methacrylic acid/ethyl acrylate copolymer or alginate appeared
intact, and also released their Zolpidem drug load at a consider-
ably slower rate (Fig. 2c). The polymer, thus, reinforced the pellet
matrix, in combination with introducing an insoluble excipient in
the pore structure, and enabled it to act as a diffusion barrier
against immediate drug release or dose dumping, i.e. rapid and
unintended release of the entire dose from a sustained release
drug vehicle [18]. In line with this reasoning, the Ko D sample,
having the most well dispersed polymer in the pellet matrix
according to observations made using SEM (Fig. 1), was also
delaying drug release the most (Fig. 2c) because of its ability to
preserve the pellet shape during release in low pH. Decreasing the
polymer concentration to a half (Ko-h D), lead to an increased
drug release rate in pH 1, Fig. 2c. Using powder, instead of pre-
dissolved polymer in the pellet synthesis, impaired the polymer
dispersion, as seen in SEM (Fig. 1d), which also resulted in an
increased drug release rate in pH 1 (compare Ko D and Ko P in
Fig. 2c). Interestingly, because the solubility of PEG is not pH
sensitive (Table 1), it dissolves well in both acidic and more
neutral environments, allowing the pore network to open up
during dissolution and leading to a faster release of Zolpidem
than from the other pellets under study (Fig. 2c). Although
Alginate appeared less well-dispersed in the pellets (Fig. 1e and
f) compared to Kollicoat powder (Fig. 1d), the Alginate containing
pellets released Zolpidem at a slower rate than Kollicoat contain-
ing ones. This is most probably related to the different polymers
ability to dissolve, diffuse and re-precipitate during release, which
is also the likely explanation for the difference in release rate
between the alginate polymers consisting of higher (GcE70%, Alg-
G) and lower (GcE30%, Alg-M) amounts of guluronic acid. Apart
from reinforcing the geopolymer pellet matrix, the anionic Alginate
polymer may also interact with the cationic Zolpidem (pKa 6.4) via
electrostatic interactions, thus, causing differences in the Zoldipem
release rate from the two different Alginate containing samples.
Even though both Ko and Alg powders acted as pore formers
by inducing micrometer sized voids in the pellet structure (Fig. 1),
all pellets containing polymer excipients that were analyzed in
pH 6.8 released less or the same amount of drug in 24 h at this pH
as compared to the Control sample, Fig. 2d. Since the geopolymer is
inert at pH 6.8 [10], the dissolved polymer is hindered from diffusing
out, and might consequently restrain the drug by partially clogging
the native geopolymer pores probably in combination with forma-
tion of a polymer ﬁlm in the pore structure. The observed differ-
ences in release rate at pH 6.8 between the compositions under
study are, thus, most likely caused by the varying capability of the
tested polymers to sterically and electrostatically interact with the
drug on its diffusive motion out of the pellet matrix.
In addition to the polymers listed in Table 1, the polymer
excipient Eastmam Cellulose Acetate Phthalate was also tested.
Pellets containing Cellulose Acetate Phthalate did not differ
signiﬁcantly in their release behavior of Zolpidem compared to
Control samples.4. Summary and conclusions
Pellets made from one geopolymer formulation with the com-
mercially available polymer excipients methacrylic acid/ethyl acry-
late copolymer, PEG and Alginate were prepared containing the
sedative drug Zolpidem, herein acting as a model drug for the highlypotent opioid Fentanyl. Scanning electron microscopy, compression
strength tests and drug release experiments (in pH 1 and 6.8) were
performed. The SEM micrographs showed that the polymer excipi-
ents were well dispersed in the pellet microstructure when they
were dissolved prior to synthesis, but induced micrometer-sized
voids when added in powder form or PEG in solution. The high
compression strength of the pure geopolymers was maintained after
addition of pre-dissolved polymer excipients during synthesis,
whereas it decreased somewhat for geopolymers with polymers
added in powder form. The maintained mechanical stability of the
geopolymer structure after addition of excipients is a prerequisite to
hamper dose dumping via voluntary or in-voluntary pellet crushing.
The drug release rates in pH 1 decreased for compositions
containing polymer excipients as compared to the corresponding
rate for a pure geopolymer Control sample, except for pellets
containing PEG. The polymer excipients in the geopolymer pellets
were anticipated to have several roles during drug release. The
major role was probably to retain a barrier towards drug diffusion
and release by keeping the pellet together in pH 1. Apart from also
acting as a pore-forming agent, it might have provided additional
ion-exchange sites for the charged drug molecules to further
delay release in pH 1. Drug releases in pH 6.8 from pellets with
polymer excipients were slower or comparable to release from
the Control sample. The reduced drug release rate at pH 6.8 may
be due to a clogging behavior of the dissolved polymer excipients,
probably in combination with formation of a polymer ﬁlm in the
pore structure, hindering drug diffusion in the native geopolymer
pores in the inert matrix.
Improving acid resistance while retaining mechanical stability
of geopolymers are crucial for being able to introduce such
materials as delivery vehicles for sustained and safe oral delivery
of highly potent opioids to the market. The results presented in
this work, together with those in a recent study on the inﬂuence
of drug distribution and solubility on release from geopolymers
[19], open up the possibility to create safe, oral, one-tablet-a-day
systems to treat chronic pain.Acknowledgment
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